Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, Pa., May 05, 2026 ...
Basal cell carcinoma (BCC) represents the most prevalent form of skin cancer, with research efforts increasingly focused on elucidating its molecular underpinnings and improving therapeutic strategies ...
Medicus Pharma Ltd. MDCX on Wednesday reported expanded Phase 2 SKNJCT-003 study data showing a clear dose-response ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...
Amy A. Vaughan, M.D. Dermatology introduces Gentlecure, the most advanced nonsurgical treatment for nonmelanoma skin cancer, ...
Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications ...
Add Yahoo as a preferred source to see more of our stories on Google. Skin cancer is the most common type of cancer in the United States with 5.4 million new cases of the disease reported every year.
Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results